Search research articles
Contact Us
Filters
Showing results (241-250 of 352) with videos related to
Page
of 36
Sort By:
Analytical Chemistry
|
April 15, 1990
Laser desorption electron impact: application to a study of the mechanism of conjugation of glutathione and cyclophosphamide
Z M Yuan, C Fenselau, D M Dulik, et al.
Stem Cell Research
|
February 20, 2026
Generation of two isogenic sickle cell disease induced pluripotent stem cell lines from ovarian fibroblasts
Mitchell R Harancher, Livianna K Myklebust, Meena Sukhwani, et al.
Cancer Research
|
June 1, 1985
Synergistic effect of 4-hydroperoxycyclophosphamide and etoposide on a human promyelocytic leukemia cell line (HL-60) demonstrated by computer analysis
T T Chang, S C Gulati, T C Chou, et al.
Plos One
|
January 28, 2014
Patterning the cone mosaic array in zebrafish retina requires specification of ultraviolet-sensitive cones
Pamela A Raymond, Steven M Colvin, Zahera Jabeen, et al.
Journal of Neurosurgery
|
December 1, 1991
Multidrug resistance gene (MDR1) expression in human brain tumors
M W Nabors, C A Griffin, B A Zehnbauer, et al.
Cancer Chemotherapy and Pharmacology
|
October 29, 2000
Camptothecin analogues with enhanced antitumor activity at acidic pH
D J Adams, M W Dewhirst, J L Flowers, et al.
Cancer Treatment Reports
|
January 1, 1987
High-performance liquid chromatographic assay for taxol in human plasma and urine and pharmacokinetics in a phase I trial
S M Longnecker, R C Donehower, A E Cates, et al.
Medical and Pediatric Oncology
|
September 1, 1995
Cyclophosphamide in combination with sargramostim for treatment of recurrent medulloblastoma
A Moghrabi, H Fuchs, M Brown, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1989
Pharmacokinetics of busulfan: correlation with veno-occlusive disease in patients undergoing bone marrow transplantation
L B Grochow, R J Jones, R B Brundrett, et al.
Cancer Chemotherapy and Pharmacology
|
April 29, 1998
Enhancement of irinotecan (CPT-11) activity against central nervous system tumor xenografts by alkylating agents
C A Coggins, G B Elion, P J Houghton, et al.
Page
of 36
Search research articles
Search
Showing results (241-250 of 352) with videos related to
Sort By:
Page
of 36
Analytical Chemistry
|
April 15, 1990
Laser desorption electron impact: application to a study of the mechanism of conjugation of glutathione and cyclophosphamide
Z M Yuan, C Fenselau, D M Dulik, et al.
Stem Cell Research
|
February 20, 2026
Generation of two isogenic sickle cell disease induced pluripotent stem cell lines from ovarian fibroblasts
Mitchell R Harancher, Livianna K Myklebust, Meena Sukhwani, et al.
Cancer Research
|
June 1, 1985
Synergistic effect of 4-hydroperoxycyclophosphamide and etoposide on a human promyelocytic leukemia cell line (HL-60) demonstrated by computer analysis
T T Chang, S C Gulati, T C Chou, et al.
Plos One
|
January 28, 2014
Patterning the cone mosaic array in zebrafish retina requires specification of ultraviolet-sensitive cones
Pamela A Raymond, Steven M Colvin, Zahera Jabeen, et al.
Journal of Neurosurgery
|
December 1, 1991
Multidrug resistance gene (MDR1) expression in human brain tumors
M W Nabors, C A Griffin, B A Zehnbauer, et al.
Cancer Chemotherapy and Pharmacology
|
October 29, 2000
Camptothecin analogues with enhanced antitumor activity at acidic pH
D J Adams, M W Dewhirst, J L Flowers, et al.
Cancer Treatment Reports
|
January 1, 1987
High-performance liquid chromatographic assay for taxol in human plasma and urine and pharmacokinetics in a phase I trial
S M Longnecker, R C Donehower, A E Cates, et al.
Medical and Pediatric Oncology
|
September 1, 1995
Cyclophosphamide in combination with sargramostim for treatment of recurrent medulloblastoma
A Moghrabi, H Fuchs, M Brown, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1989
Pharmacokinetics of busulfan: correlation with veno-occlusive disease in patients undergoing bone marrow transplantation
L B Grochow, R J Jones, R B Brundrett, et al.
Cancer Chemotherapy and Pharmacology
|
April 29, 1998
Enhancement of irinotecan (CPT-11) activity against central nervous system tumor xenografts by alkylating agents
C A Coggins, G B Elion, P J Houghton, et al.
Page
of 36